~人生道路,一定會有許多未知的轉角,但我相信在下一個轉角,會遇到人生中最美好的事情~
2016年[串臉藝起來] NF畫展活動,將於11月24日開幕了~歡迎大家一起熱情參與。詳情請參照官網最新訊息辦法。
衛教資訊

症狀 醫療測試方法  測試期別
CNS Cancer, Meningioma, Hemangioblastoma Drug: Sunitinib  Phase 2
Intracranial Hemangiopericytoma, Neurofibromatosis 
Cutaneous Neurofibromas  Procedure: Erbium-YAG laser vaporization  Phase 2
Phase 3
Malignant Peripheral Nerve Sheath Tumors Drug: everolimus Phase 2
Sarcoma  Drug: bevacizumab 
neurofibromatosis1 (NF1) Drug: Sorafenib (Nexavar) Phase 2
Recurrent or Progressive Optic Pathway Gliomas (OPG)
Recurrent or Progressive Low-grade Glioma 
Acoustic Schwannoma, NF1 and NF2  Biological: bevacizumab  Phase 2
Glioma Other: Laboratory Biomarker Analysis Phase 1
Neurofibromatosis Type 1 Other: Pharmacological Study Phase 2
Recurrent Childhood Pilocytic Astrocytoma Drug: Selumetinib   
Recurrent Childhood Visual Pathway Glioma     
Neurofibromatosis Type 1 Drug: Lenalidomide Phase 2
Recurrent Childhood Pilocytic Astrocytoma Other: Pharmacological Study
Recurrent Childhood Visual Pathway Glioma  
Neurofibromatosis Type 2, Vestibular Schwannomas Drug: RAD001 Phase 0
Meningiomas
Vestibular Schwannoma, NF2  Drug: lapatinib  Phase 0
Vestibular Schwannoma, Meningioma, NF 2  Drug: AR-42 (HDAC inhibitor)  Phase 0
Low-Grade Gliomas, Malignant Neoplasms, Brain Drug: MEK162  Phase 1
Soft Tissue Neoplasms  Phase 2
Malignant Peripheral Nerve Sheath Tumors (MPNST) Drug: ganetespib Phase 1
Sarcoma  Drug: Sirolimus  Phase 2
Plexiform Neurofibroma  Drug: PEG-Intron  Phase 2
Solid Tumor and Hematologic Malignancies  Drug: MEK162  Phase 2

網頁提供的資料僅供參考,並非醫療上的建議,也不構成上市臨床活動的認可。以美國和歐洲的資訊來源所整理的醫療試驗

李銘仁整理 2015-12-07